DICE Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
01 Apr 2022	Form 3: Doyle Mittie, Director Holds 0 shares of No securities beneficially held
01 Apr 2022	Form 3: Bowers Lisa, Director Holds 0 shares of No securities beneficially held
14 Sep 2021	Form 3: Northpond Ventures GP, Llc, 10% owner and 4 others
14 Sep 2021	Form 3: Zachary Stephen, Director Holds 0 shares of No securities beneficially held
14 Sep 2021	Form 3: Scopa James Paul, Director Holds 69,000 shares of Common Stock
14 Sep 2021	Form 3: Ra Capital MANAGEMENT, L.p., Director and 4 others
14 Sep 2021	Form 3: Gandhi Shaan-Chirag C, Director Holds 0 shares of No securities beneficially held
14 Sep 2021	Form 3: Tetlow Sharon, Director Holds 69,000 shares of Common Stock
14 Sep 2021	Form 3: Scheller Richard H, Director Holds 113,000 shares of Common Stock
14 Sep 2021	Form 3: Timothy Lu, CMO Holds 215,835 shares of Common Stock
14 Sep 2021	Form 3: Simson Jake, Director Holds 0 shares of No securities beneficially held
14 Sep 2021	Form 3: Jacobsen John R., CSO Holds 231,625 shares of Common Stock
14 Sep 2021	Form 3: Robertson Scott M., CFO & CBO Holds 284,600 shares of Common Stock
14 Sep 2021	Form 3: Judice Kevin, Director Holds 971,644 shares of Common Stock

Comments